Print Friendly, PDF & Email

HealthTech Review April, 30 2012

Latest Version of Vivid E9™ Cardiac Ultrasound System with 4D TEE Probe Receives FDA Clearance

GE Healthcare has announced the FDA clearance and availability of the latest version of its Vivid E9™cardiovascular ultrasound system.  The Vivid E9 Breakthrough 2012 (BT12) includes a 4D transducer for transesophageal echocardiography (TEE), and also provides innovative tools designed to help improve workflow efficiency through simplified image acquisition, intuitive navigation and advanced yet easy to use quantification.

Read more…

 

Phase 3 Results for GE Healthcare Imaging Agent Flutemetamol Presented at American Academy of Neurology Meeting

GE Healthcare announced results from four pooled brain biopsy studies, as well as key results from a brain autopsy study, of the investigational PET amyloid imaging agent, [18F]flutemetamol. The data showed that both biopsy and autopsy study images had high sensitivity and specificity, and that strong concordance exists between [18F]flutemetamol PET images and Alzheimer’s disease-associated beta amyloid brain pathology. The data confirm the potential of [18F]flutemetamol as an imaging agent to detect beta amyloid plaque, a pathology associated with Alzheimer’s disease (AD), in living patients.

Read more…

 

DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging Demonstrates Impact on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome

GE Healthcare presented the results of a randomized study analyzing the effect of DaTscan™ (Ioflupane I 123 Injection) SPECT imaging in a group of adult patients with clinically uncertain parkinsonian syndromes (CUPS) as part of 1-year follow up from imaging baseline. It was the first world-wide prospective trial including US experience, using selected endpoints in patients with CUPS. The findings, presented at the 2012 American Academy of Neurology Meeting, showed significant differences in clinical management, diagnosis, and physician confidence of diagnosis (CoD) for a group of patients with CUPS who had been imaged with DaTscan.

 Igor D Grachev, Andreas Kupsch, Nin Bajaj et. al. Impact of DaTscan™ SPECT Imaging on Clinical Management, Diagnosis, and Confidence of Diagnosis in Patients with Clinically Uncertain Parkinsonian Syndromes: A Prospective 1-year Follow-up Study. Poster presented at 2012 American Academy of Neurology Annual Meeting.

Read more…

 

GE Healthcare Brings Rapid Cell Characterization to the Benchtop with Launch of New Image Cytometry System

GE Healthcare announced the launch of Cytell™ Image Cytometer, a benchtop-sized image cytometer for rapid cell characterization which introduces researchers to a new, simpler, faster and more productive way to conduct their cell analysis. The new Cytell™ Image Cytometer enables researchers to capture detailed data about their cells quickly while using minimal sample volumes. Data can be acquired for up to eight samples at a time and results are delivered through an intuitive graphical interface in less than two-and-a-half minutes.

Read more…

 

Improving the Patient Experience One Exam at the Time

Conceived by GE Global Design and created by PDC, a leading imaging suite design firm as well as Joey Fischer, a prominent nature photographer, GE Healthcare MR recently introduced the Caring MR Suite to create a more natural, open and serene environment for exams: a reflection of the award-winning design elements of GE’s wide bore MR systems.  Through its interactive design, patients are able to pick one of 16 different themes from an intuitive interface custom-built for the iPad®. Each theme features mood lighting, music and high resolution nature photography to accompany them during their exam.

Read more…

 

GE Healthcare Technology Helps Make UK Hospital among “Top of Class”

The first UK installation of the GE Healthcare Discovery* MR750w 3.0T has been unveiled at the Norfolk and Norwich University Hospital (NNUH) in East Anglia in a purpose built Clinical Imaging and Research Centre, which will provide a platform for ground-breaking research as well as exceptional patient care. The Discovery MR750w 3.0T, which can scan patients feet first rather than head first, introduces a larger 70cm patient ‘bore’ (the area where the person lays to be scanned), and a patient-friendly design to help alleviate patient anxiety and stress during the scan.

Read more…